| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.84B | 26.40B | 25.54B | 24.99B | 27.11B | 23.62B |
| Gross Profit | 3.94B | 4.18B | 3.79B | 3.74B | 3.49B | 3.02B |
| EBITDA | 2.34B | 2.55B | 2.34B | 2.45B | 2.03B | 1.79B |
| Net Income | 756.69M | 636.22M | 746.44M | 796.77M | 1.49B | 523.15M |
Balance Sheet | ||||||
| Total Assets | 37.19B | 40.25B | 38.38B | 38.14B | 37.84B | 36.88B |
| Cash, Cash Equivalents and Short-Term Investments | 4.73B | 5.73B | 5.27B | 5.61B | 5.03B | 4.11B |
| Total Debt | 8.29B | 9.55B | 8.54B | 9.48B | 10.34B | 10.85B |
| Total Liabilities | 13.18B | 14.70B | 13.96B | 14.59B | 15.92B | 16.80B |
| Stockholders Equity | 21.09B | 22.11B | 21.31B | 20.62B | 19.28B | 17.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 871.19M | 966.62M | 1.60B | 1.69B | -2.18B |
| Operating Cash Flow | 0.00 | 1.68B | 2.45B | 2.15B | 2.68B | 1.32B |
| Investing Cash Flow | 0.00 | -560.49M | -1.18B | -749.77M | -1.65B | -2.13B |
| Financing Cash Flow | 0.00 | -301.86M | -1.14B | -1.03B | -948.09M | 1.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥17.25B | 16.51 | ― | 1.49% | 0.06% | 5.50% | |
64 Neutral | ¥17.09B | 8.70 | ― | 3.62% | 1.03% | 8.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥34.13B | 18.14 | ― | 2.59% | 0.68% | 33.74% | |
60 Neutral | ¥68.38B | 10.29 | ― | 2.18% | 6.54% | 140.15% | |
56 Neutral | ¥6.17B | 16.24 | ― | 2.29% | -0.18% | -65.47% | |
54 Neutral | ¥16.73B | 30.45 | ― | 1.13% | 3.36% | -15.06% |